Olympic testing
HFL Sport Science (HFL), a part of the LGC Group (Teddington, Middlesex, UK) and one of the world’s largest sports drug surveillance laboratories, is preparing for its role testing the horses competing in equestrian events at the Olympic and Paralympic Games.
HFL Sport Science (HFL), a part of the LGC Group (Teddington, Middlesex, UK) and one of the world’s largest sports drug surveillance laboratories, is preparing for its role testing the horses competing in equestrian events at the Olympic and Paralympic Games.
HFL screens for approximately 2,000 different prohibited substances in each urine or blood sample taken from competing animals. This service is delivered within a Quality System framework that is externally accredited to the ISO 17025 Standard for Testing and Calibration Laboratories. The company has nearly 50 years’ experience in the science of sports doping control, including experience testing within the framework of the World Anti-Doping Agency (WADA) and testing human and animal food supplements for substances prohibited in sport.
Jeremy Cook, managing director of the LGC Health Sciences Division, commented: “We are very proud to be playing a small but important role in the London 2012 Olympic and Paralympic Games. We are confident that our experienced scientists and technology will enable us to meet the exacting standards required for such an important and prestigious event.”
For more information please visit www.lgc.co.uk
This story originally appeared in The Column. Click here to view that issue.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
